Fractional flow reserve: current status

A.V. Khokhlov, M.V. Shymanko, M.V. Stan

References  

 1. Adjedj J, Toth GG, Johnson NP, Pellicano M, Ferrara A, Floré V, Di Gioia G, Barbato E, Muller O, De Bruyne B. Intracoronary Adenosine: Dose-Response Relationship With Hyperemia. JACC. Cardiovasc Interv. 2015;8:1422–1430. doi: 10.1016/j.jcin.2015.04.028.

2. Ahn JM, Park DW, Shin ES, Koo BK, Nam CW, Doh JH, Kim JH, Chae IH, Yoon JH, Her SH, Seung KB, Chung WY, Yoo SY, Lee JB, Choi SW, Park K, Hong TJ, Lee SY, Han M, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park SJ; IRIS-FFR Investigators. Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective Registry. Circulation. 2017;29 [Epub ahead of print]. doi: 10.1161/circulationaha.117.030551.
3. Bech GJ, De Bruyne B, Pijls NH,de Muinck ED, Hoorntje JCA, Escaned J, Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103:2928–2934. doi: 10.1161/01.cir.103.24.2928.
4. Christou MA, Siontis GC, Katritsis DG, Ioannidis JP. Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. Am J Cardiol. 2007;99:450–456. doi: 10.1016/j.amjcard.2006.09.092.
5. Curzen N, Rana O, Nicholas Z, Golledge P, Zaman A, Oldroyd K, Hanratty C, Banning A, Wheatcroft S, Hobson A, Chitkara K, Hildick-Smith D, McKenzie D, Calver A, Dimitrov BD, Corbett S.. Does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain?: the RIPCORD study. Circ Cardiovasc Interv. 2014;7:248–255. doi: 10.1161/circoutcomes.117.004191.
6. Dattilo PB, Prasad A, Honeycutt E, Wang TY, Messenger JC. Contemporary patterns of fractional flow reserve and intravascular ultrasound use among patients undergoing percutaneous coronary intervention in the United States: insights from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2012;60:2337–2339. doi: 10.1016/j.jacc.2012.08.990.
7. Davies JE, Sen S, Dehbi HM, Al-Lamee R, Petraco R, Nijjer SS, Bhindi R, Lehman SJ, Walters D, Sapontis J, Janssens L, Vrints CJ, Khashaba A, Laine M, Van Belle E, Krackhardt F, Bojara W, Going O, Härle T, Indolfi C, Niccoli G, Ribichini F, Tanaka N, Yokoi H, Takashima H, Kikuta Y, Erglis A, Vinhas H, Canas Silva P, Baptista SB, Alghamdi A, Hellig F, Koo BK, Nam CW, Shin ES, Doh JH, Brugaletta S, Alegria-Barrero E, Meuwissen M, Piek JJ, van Royen N, Sezer M, Di Mario C, Gerber RT, Malik IS, Sharp ASP, Talwar S, Tang K, Samady H, Altman J, Seto AH, Singh J, Jeremias A, Matsuo H, Kharbanda RK, Patel MR, Serruys P, Escaned J. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. New Engl J Med. 2017;376:1824–1834. doi: 10.1056/nejmc1711333.
8. De Bruyne B, Baudhuin T, Melin JA, Pijls NH, Sys SU, Bol A, Paulus WJ, Heyndrickx GR, Wijns W. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation. 1994;89:1013–1022. doi: 10.1161/01.CIR.89.3.1013.
9. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P et al., for the FAME 2 Trial Investigators*. Fractional flow reserve-guided PCI for stable coronary artery disease. New Engl J Med. 2014;371:1208–1217. doi: 10.1056/nejmx140052.
10. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PAL, Piroth Z, Jagic N, Möbius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, et al., for the FAME 2 Trial Investigators*. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. New Engl J Med. 2012;367:991–1001. doi: 10.1056/nejmx120078.
11. Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L; DANAMI-3—PRIMULTI Investigators. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3 – PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015;386:665–671. doi: 10.3410/f.725787766.793509725.
12. Götberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L, Olsson S-E, Öhagen P, Olsson H, Omerovic E, Calais F, Lindroos P, et al., for the iFR-SWEDEHEART Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. New Engl J Med. 2017;376:1813–1823. doi: 10.3410/f.727423277.793532843.
13. Hakeem A, Edupuganti MM, Almomani A. et al. Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve. J Am Coll Cardiol. 2016;68:1181–1191. doi: 10.1016/j.jacc.2016.06.035.
14. Hwang D, Jeon KH, Lee JM. et al. Diagnostic Performance of Resting and Hyperemic Invasive Physiological Indices to Define Myocardial Ischemia: Validation With 13N-Ammonia Positron Emission Tomography. JACC Cardiovasc Interv. 2017;10:751–760. doi: 10.1016/j.jcin.2016.12.015.
15. Jeremias A, Maehara A, Généreux P. et al. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. J Am Coll Cardiol. 2014;63:1253–1261. doi: 10.1016/j.ihj.2018.10.215.
16. Kolh P, Windecker S, Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2014;46:517–592. doi: 10.1093/eurheartj/ehu278.
17. Levine GN, Bates ER, Blankenship JC. et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574–651. doi: 10.1002/ccd.24776.
18. Li J, Elrashidi MY, Flammer AJ. et al. Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Eur Heart J. 2013;34:1375–1383. doi: 10.1093/eurheartj/eht005.
19. Lotfi A, Jeremias A, Fearon WF. et al. Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: a consensus statement of the Society of Cardiovascular Angiography and Interventions. Catheter. Cardiovasc. Interv. 2014;83:509–518. doi: 10.1002/ccd.25222.
20. Mangiacapra F, Bressi E, Sticchi A. et al. Fractional flow reserve (FFR) as a guide to treat coronary artery disease. Expert Rev Cardiovasc Therapy. 2018;16:465–477. doi: 10.1080/14779072.2018.1489236.
21. Muller O, Mangiacapra F, Ntalianis A. et al. Long-term follow-up after fractional flow reserve-guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis. JACC Cardiovasc Interv. 2011;4:1175–1182. doi: 10.1016/j.jcin.2011.09.007.
22. Neumann F-J, Sousa-Uva M, Ahlsson A. et al. A Byrne Jean-Philippe Collet Volkmar Falk Stuart J Head 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40, Issue 2:87–165. doi: 10.1093/eurheartj/ehy394.
23. Patel MR, Calhoon JH, Dehmer GJ. et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2017. 69 (5):570–591. doi: 10.1016/j.jacc.2016.10.034.
24. Patel MR, Calhoon JH, Dehmer GJ. et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2017;69:2212–2241. doi: 10.1007/s12350-017-1070-1.
25. Pijls NH, Van Gelder B, Van der Voort P. et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92:3183–3193. doi: 10.1161/01.cir.92.11.3183.
26. Pijls NHJ, van Son JAM, Kirkeeide RL. et al. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87:1354–1367. doi: 10.1161/01.cir.87.4.1354.
27. Rioufol G, Mewton N, Rabilloud M. et al. Functional Testing Underlying Revascularization: The FUTURE Trial. Presented at American Heart Association Scientific Sessions 2016 on November 14, 2016. New Orleans, LA. doi: 10.1358/dof.2016.041.12.2571709.
28. Sen S, Escaned J, Malik I.S. et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol. 2012;59:1392–1402. doi: 10.1016/j.jacc.2011.11.006.
29. Shlofmitz E, Jeremias A. FFR in 2017: Current Status in PCI Management https://www.acc.org/latest-in-cardiology/articles/2017/05/25/08/34/ffr-in-2017-current-status-in-pci-management.
30. Smits PC, Abdel-Wahab M, Neumann FJ. et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. New Engl J Med. 2017;376:1234–1244. doi: 10.1056/nejmc1706275.
31. Tonino PA, De Bruyne B, Pijls NH. et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. New Engl J Med. 2009;360:213–224. doi: 10.1056/NEJMoa0807611.
32. Van Belle E, Rioufol G, Pouillot C. et al. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation. 2014;129:173–185. doi: 10.1161/circulationaha.113.006646.
33. Vergallo R, Uemura S, Soeda T. et al. Prevalence and Predictors of Multiple Coronary Plaque Ruptures: In Vivo 3-Vessel Optical Coherence Tomography Imaging Study. Arterioscler Thromb Vasc Biol. 2016;36:2229–2238. doi: 10.1161/atvbaha.116.307891.
34. Zimmermann FM, Ferrara A, Johnson NP. et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J. 2015;36:3182–3188. doi: 10.1093/eurheartj/ehv452.

[PDF] [Contents]